A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease

Mild cognitive impairment (MCI) is a precursor phase of Alzheimer’s disease (AD). As current treatments may be effective only at the early stages of AD, it is important to track MCI patients who will convert to AD. The aim of this study is to develop a high performance semi-mechanism based approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haochen, Zhou, Xiaoting, Jiang, Hao, He, Hua, Liu, Xiaoquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896009/
https://www.ncbi.nlm.nih.gov/pubmed/27273250
http://dx.doi.org/10.1038/srep26712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896009/
https://www.ncbi.nlm.nih.gov/pubmed/27273250
http://dx.doi.org/10.1038/srep26712

Ejemplares similares